Tumor spread through air spaces is a useful predictor of recurrence and prognosis in stage I lung squamous cell carcinoma, but not in stage II and III

被引:51
|
作者
Yanagawa, Naoki [1 ]
Shiono, Satoshi [2 ]
Endo, Makoto [2 ]
Ogata, Shin-ya [1 ]
机构
[1] Yamagata Prefectural Cent Hosp, Dept Diagnost Pathol, 1800 Aoyagi, Yamagata, Yamagata 9902292, Japan
[2] Yamagata Prefectural Cent Hosp, Dept Thorac Surg, Yamagata, Yamagata, Japan
关键词
Lung squamous cell carcinoma; Spread through air spaces; Recurrence; Prognosis; RESECTION; IMPACT;
D O I
10.1016/j.lungcan.2018.03.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Tumor spread through air spaces (STAS) is a newly identified invasion pattern in lung adenocarcinoma. This study aimed to analyze and validate the clinical impact of tumor STAS in surgically resected lung squamous cell carcinoma (SQCC). Materials and methods: We retrospectively reviewed 220 patients with lung SQCC. Tumor STAS was defined as detached tumor cells within the air spaces in the lung parenchyma beyond the edge of the main tumor. Statistical analyses were conducted to investigate the proportion of STAS and the relationship between the presence of STAS and clinicopathological factors, including clinical outcome. Results: STAS was identified in 42 of 220 patients (19.1%). The patients with STAS had a significantly worse 5 year recurrence-free survival (RFS) and 5-year overall survival (OS) than those without STAS (5-year RFS: 37.4% vs. 68.4%; p = 0.0006; 5-year OS: 50.2% vs. 71.4%, p = 0.0078) in stage I, but not in stage II and III. A multivariate analysis showed that the presence of STAS was an independent predictive factor of recurrence (hazard ratio = 3.27; 95% confidence interval, 1.7-6.29; p = 0.0004) and an independent prognostic factor (hazard ratio = 3.01; 95% confidence interval, 1.54-5.89; p = 0.0013) in stage I, but not in stage II and III. Conclusion: We found that STAS was detected in 19.1% of surgical resected SQCC, and it was associated with recurrence and worse survival in stage I SQCC, but not in stage II and III SQCC. Therefore, we suggest that STAS is a useful predictor of recurrence and prognosis in stage I lung SQCC.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 50 条
  • [41] Could Tumor Spread Through Air Spaces Identify Distinct Subgroup With Poor Prognosis in Lung Pleomorphic Carcinoma?
    Song, Tieniu
    Lin, Yidan
    CHEST, 2019, 156 (03) : 631 - 632
  • [42] Immune-active tumor-adjacent tissues are associated with favorable prognosis in stage I lung squamous cell carcinoma
    Ying, Lisha
    Zhang, Chunliu
    Reuben, Alexandre
    Tian, Yiping
    Jin, Jiaoyue
    Wang, Canming
    Bai, Jing
    Liu, Xinyuan
    Fang, Jianfei
    Feng, Tingting
    Xu, Chenyang
    Zhu, Rui
    Huang, Minran
    Lyu, Yingqi
    Lu, Tingting
    Pan, Xiaodan
    Zhang, Jianjun
    Su, Dan
    ISCIENCE, 2023, 26 (09)
  • [43] Neoadjuvant Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma
    Kawai, Takaharu
    Kochi, Mitsugu
    Fujii, Masashi
    Song, Keio
    Hagiwara, Ken
    Watanabe, Megumu
    Matsuno, Yoritaka
    Suda, Hiroshi
    Yagi, Renpei
    Takayama, Tadatoshi
    ANTICANCER RESEARCH, 2017, 37 (06) : 3301 - 3306
  • [44] Clinical implication of tumour spread through air spaces in pathological stage I lung adenocarcinoma treated with lobectomy
    Yi, Eunjue
    Lee, Jeong Hyeon
    Jung, Younggi
    Chung, Jae Ho
    Lee, Youngseok
    Lee, Sungho
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2021, 32 (01) : 64 - 72
  • [45] High VEGFA pathway expression predicts good prognosis in stage I squamous cell carcinoma of the lung
    Agorreta, Jackeline
    Pajares, Maria J.
    Larrayoz, Marta
    Vesin, Aurelien
    Exponda, Teresa
    Zudaire, Isabel
    Torre, Wenceslao
    Lozano, Maria D.
    Gurpide, Alfonso
    Brambilla, Elisabeth
    Brambilla, Christian
    Wistuba, Ignacio I.
    Behrens, Carmen
    Timsit, Jean -Francois
    Pio, Ruben
    Field, John
    Montuenga, Luis M.
    CANCER RESEARCH, 2011, 71
  • [46] Tumor-associated CD163+ macrophage as a predictor of tumor spread through air spaces and with CD25+ lymphocyte as a prognostic factor in resected stage I lung adenocarcinoma
    Yoshida, Chihiro
    Kadota, Kyuichi
    Yamada, Kaede
    Fujimoto, Syusuke
    Ibuki, Emi
    Ishikawa, Ryo
    Haba, Reiji
    Yokomise, Hiroyasu
    LUNG CANCER, 2022, 167 : 34 - 40
  • [47] In Early-Stage Lung Adenocarcinomas, Survival by Tumor Size (T) is Further Stratified by Tumor Spread through Air Spaces
    Eguchi, Takashi
    Kameda, Koji
    Lu, Shaohua
    Bott, Matthew
    Tan, Kay See
    Jones, David
    Travis, William
    Adusumilli, Prasad
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S270 - S271
  • [48] Radiation treatment of glottic squamous cell carcinoma, stage I and II: Analysis of factors affecting prognosis
    Franchin, G
    Minatel, E
    Gobitti, C
    Talamini, R
    Sartor, G
    Caruso, G
    Grando, G
    Politi, D
    Gigante, M
    Toffoli, G
    Trovo, MG
    Barzan, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (03): : 541 - 548
  • [49] Histological Risk Model Is a Useful and Inexpensive Tool To Assess Risk of Recurrence and Death in Stage I or II Squamous Cell Carcinoma of Oral Tongue
    Sinha, Namita
    Rigby, Matthew
    McNeil, Michael
    Makki, Fawaz
    Taylor, S. Mark
    Hart, Robert
    Trites, Jonathan
    Bullock, Martin
    MODERN PATHOLOGY, 2015, 28 : 331A - 331A
  • [50] Histological Risk Model Is a Useful and Inexpensive Tool To Assess Risk of Recurrence and Death in Stage I or II Squamous Cell Carcinoma of Oral Tongue
    Sinha, Namita
    Rigby, Matthew
    McNeil, Michael
    Makki, Fawaz
    Taylor, S. Mark
    Hart, Robert
    Trites, Jonathan
    Bullock, Martin
    LABORATORY INVESTIGATION, 2015, 95 : 331A - 331A